Search hospitals > Illinois > Chicago
University of Chicago
Claim this profileChicago, Illinois 60637
Global Leader in Skin Cancer
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Breast Cancer
Conducts research for Uterine Tumors
Conducts research for Non-Small Cell Lung Cancer
1389 reported clinical trials
186 medical researchers
Summary
University of Chicago is a medical facility located in Chicago, Illinois. This center is recognized for care of Skin Cancer, T-Lymphoblastic Leukemia/Lymphoma, Breast Cancer, Uterine Tumors, Non-Small Cell Lung Cancer and other specialties. University of Chicago is involved with conducting 1,389 clinical trials across 1,693 conditions. There are 186 research doctors associated with this hospital, such as Rita Nanda, MD, Ardaman Shergill, MD, Ami V Desai, and Christine M. Bestvina.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
HER2 positive
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderFLT3 positive
BCR-ABL1 positive
HLA-A positive
Top PIs
Rita Nanda, MDUniversity of Chicago Comprehensive Cancer Center8 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
24 reported clinical trials
47 drugs studied
Ardaman Shergill, MDUniversity of Chicago Comprehensive Cancer Center2 years of reported clinical research
Expert in Stomach Cancer
Studies Colorectal Cancer
25 reported clinical trials
63 drugs studied
Ami V DesaiUniversity of Chicago Comprehensive Cancer Center4 years of reported clinical research
Expert in Neuroblastoma
Studies Uterine Tumors
22 reported clinical trials
45 drugs studied
Christine M. BestvinaUniversity of Chicago Comprehensive Cancer Center6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
21 reported clinical trials
38 drugs studied
Clinical Trials running at University of Chicago
Breast Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Coronavirus
Prostate Cancer
Lung Cancer
Multiple Myeloma
Heart Failure
Crohn's Disease
Stroke
Avelumab + Palbociclib/Hydroxychloroquine
for Breast Cancer
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are found to harbor disseminated tumor cells (DTCs) in the bone marrow after definitive surgery and standard adjuvant therapy.
Recruiting3 awards Phase 212 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting2 awards Phase 33 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Chicago?
Where is University of Chicago located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Chicago accept?
What awards or recognition has University of Chicago received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.